Desonide and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Desonide (desonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Desonide. It is created by eHealthMe based on reports of 5,450 people who have side effects when taking Desonide from the FDA, and is updated regularly.

What is Desonide?

Desonide has active ingredients of desonide. It is often used in rosacea. eHealthMe is studying from 5,484 Desonide users. Check the latest studies of Desonide.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,067 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 06, 2026

5,450 people reported to have side effects when taking Desonide.
Among them, 48 people (0.88%) have Conjunctivitis exacerbated.

Could Desonide cause Conjunctivitis exacerbated?

Among these 48 people:

How long have people been on Desonide when they have Conjunctivitis exacerbated? *

What is the gender of people who have Conjunctivitis exacerbated when taking Desonide? *

female: 64.44 %
male: 35.56 %

What is the age of people who have Conjunctivitis exacerbated when taking Desonide? *

What are other drugs people take besides Desonide? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Sinus Disorder (disease of sinus): 11 people, 22.92%
Nasopharyngitis (inflammation of the nasopharynx): 11 people, 22.92%
Sinusitis (inflammation of sinus): 11 people, 22.92%
Urinary Tract Infection: 9 people, 18.75%
Peripheral Swelling: 9 people, 18.75%
Rashes (redness): 9 people, 18.75%
Chest Pain: 8 people, 16.67%
Pneumonia: 8 people, 16.67%
Itching: 7 people, 14.58%
Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 14.58%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 21 people, 43.75%
Immunodeficiency Common Variable: 8 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.33%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 2 people, 4.17%
Rashes (redness): 2 people, 4.17%
Initial Insomnia (feeling of inadequate or poor-quality sleep): 2 people, 4.17%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.08%
Burning Sensation: 1 person, 2.08%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 2.08%
Cough: 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Desonide and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Desonide:

Desonide (5,484 reports)

Browse all side effects of Desonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,067 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on desonide (the active ingredients of Desonide) and Desonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.